Shares of Becton Dickinson & Co. BDX slid 1.29% to $172.21 Friday, on what proved to be an all-around dismal trading session ...

Thermo Fisher’s last major divestment was six years ago, when it sold its anatomical pathology business to Japanese healthcare group PHC Holdings Corporation for $1.1bn. Earlier this year, Thermo ...

Becton Dickinson & Co. closed 30.77% below its 52-week high of $251.99, which the company achieved on February 3rd.

BECTON, Dickinson and Co. (BD), a multinational medical technology company, is looking to bring its testing and treatment products to more Philippine hospitals and provide training to local healthcare ...

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

So I want to thank Tom Polen, Chairman and Chief Executive Officer of Becton, Dickinson. I appreciate you're making the time. I know you're on the -- you have a lot of different priorities right now.

Szyman has spoken publicly about how she has personally benefitted from Masimo’s technologies, that include products that ...

Becton, Dickinson stock is undervalued at 12.3x earnings with a 2.5% yield. Click here for a full investment analysis of BDX ...